Eunice Nduati/Lancet Microbe
1 results
Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.Chanda, C.
Kibengo, F.
Mutua, M.
Ogada, F.
Muturi-Kioi, V.
Akis Yildirim, B. M.
Amondi, M.
Baines, A.
Basajja, V.
Borthwick, N.
Bosire, K.
Chambula, E.
Chetty, P.
Chinyenze, K.
Chirro, O.
Crook, A.
De Bont, J.
Fernandez, N.
Ejou, P.
Farah, B.
Glaze, M.
Gombe, B.
Gumbe, A.
Hayes, P.
Itwi, S.
Juma, S.
Kabarambi, A.
Kabengele, C.
Kafeero, P.
Kakande, A.
Kanungi, J.
Kidega, W.
King, D.
Mahira, R.
Malogo, R.
Matsoso, M.
Michelo, C.
Moyo, A.
Mugaba, S.
Mugenya, I.
Muhumuza, P.
Mujadidi, Y. F.
Muriuki, M.
Musale, V.
Mutua, G.
Muwowo, M.
Mwale, F.
Mwangi, I.
Nakimbugwe, M.
Namuyanja, A.
Nduati, E.
Nielsen, L.
Nyange, J.
Oino, G.
Okech, B.
Omosa-Manyonyi, G.
Otieno, D.
Palmer, S.
Phiri, H.
Ramko, K.
Rutishauser, R. L.
Sayeed, E.
Sajabi, R.
Serwanga, J.
G. T. Wee E
Wenden, C.
Cicconi, P.
Fast, P.
Gilmour, J.
Jaoko, W.
Kaleebu, P.
Kilembe, W.
Kuipers, H.
Sanders, E. J.
Hanke, T.
Lancet Microbe, (2025). 6:101041